Risk factors for the development of bladder transitional cell carcinoma following surgery for transitional cell carcinoma of the upper urinary tract

被引:50
作者
Koga, F [1 ]
Nagamatsu, H [1 ]
Ishimaru, H [1 ]
Mizuo, T [1 ]
Yoshida, K [1 ]
机构
[1] Tokyo Rosai Occupat Dis & Injuries Hosp, Dept Urol, Ota Ku, Tokyo 1430013, Japan
关键词
upper urinary tract tumor; bladder tumor; transitional cell carcinoma; risk factor;
D O I
10.1159/000050969
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
To determine the risk factors for development of transitional cell carcinoma (TCC) of the bladder (BTCC) following surgery for TCC of the upper urinary tract (UUT-TCC) in patients without history of BTCC, 85 patients surgically treated for UUT-TCC (34 female, 51 male; median age 66, range 42-85 years) were reviewed retrospectively. The Cox proportional hazards model was used to assess the association of relevant clinicopathologic factors with BTCC-free survival in patients without a history of BTCC and TCC-specific survival in all. Median follow-up duration was 35 (range 1-193) months. Six patients (7%) had previous histories of BTCC, and 6 others (7%) had concurrent BTCC at the time of surgery for UUT-TCC. Of 70 patients who had no history of BTCC and underwent follow-up cystoscopy, 24 (34%) developed BTCC during follow-up after surgery. Univariate analysis identified female sex, postoperative systemic chemotherapy, and incomplete distal ureterectomy as significant risk factors for new development of BTCC. After multivariate analysis adjusted for age and pathological (p) T stage in the TNM classification, all three factors remained significant, with respective hazard ratios of 5.56 (95% confidence interval (Cl), 1.99-15.6; p = 0.001), 3.19 (95% Cl, 1.34-7.62; p = 0.009) and 2.99 (95% Cl, 1.08-8.26; p = 0.03). Only pT stage was a significant independent risk factor for TCC-specific death. Female sex and postoperative systemic chemotherapy, as well as incomplete distal ureterectomy, are possible riks factors for development of BTCC following surgery for UUT-TCC. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:135 / 141
页数:7
相关论文
共 26 条
[2]  
Housseau F, 1997, INT J CANCER, V71, P585, DOI 10.1002/(SICI)1097-0215(19970516)71:4<585::AID-IJC13>3.0.CO
[3]  
2-B
[4]  
HUBEN RP, 1988, CANCER, V62, P2016, DOI 10.1002/1097-0142(19881101)62:9<2016::AID-CNCR2820620924>3.0.CO
[5]  
2-G
[6]  
*INT UN CANC, 1997, TNM ATL
[7]  
*JAP UR ASS JAP SO, 1990, GEN RUL CLIN PATH ST
[8]   TRANSITIONAL CELL-CARCINOMA OF THE BLADDER IN PATIENTS WITH RENAL PELVIC AND URETERAL CANCER [J].
KAKIZOE, T ;
FUJITA, J ;
MURASE, T ;
MATSUMOTO, K ;
KISHI, K .
JOURNAL OF UROLOGY, 1980, 124 (01) :17-19
[9]  
KIHARA K, 1990, CANCER RES, V50, P2848
[10]   TRANSITIONAL CELL-CARCINOMA OF THE UPPER URINARY-TRACT - PROGNOSTIC VARIABLES AND POSTOPERATIVE RECURRENCES [J].
KROGH, J ;
KVIST, E ;
RYE, B .
BRITISH JOURNAL OF UROLOGY, 1991, 67 (01) :32-36